In a 13D filing on BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), mutual fund giant ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE